×
News Home

Is Asensus Surgical Inc (ASXC) Stock a Bad Value Thursday?

Thursday, August 11, 2022 03:25 PM | InvestorsObserver Analysts
Is Asensus Surgical Inc (ASXC) Stock a Bad Value Thursday?

The 10 rating InvestorsObserver gives to Asensus Surgical Inc (ASXC) stock puts it near the middle of the Healthcare sector. In addition to scoring higher than 51 percent of stocks in the Healthcare sector, ASXC’s 10 overall rating means the stock scores better than 10 of all stocks.

Overall Score - 10
ASXC has an Overall Score of 10. Find out what this means to you and get the rest of the rankings on ASXC!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 10 means the stock is more attractive than 10 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Asensus Surgical Inc Stock Today?

Asensus Surgical Inc (ASXC) stock is unchanged 0.76% while the S&P 500 is down -0.04% as of 3:21 PM on Thursday, Aug 11. ASXC is unchanged $0.00 from the previous closing price of $0.66 on volume of 2,361,204 shares. Over the past year the S&P 500 is down -5.38% while ASXC is down -71.12%. ASXC lost -$0.30 per share the over the last 12 months. Click Here to get the full Stock Report for Asensus Surgical Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App